ZeptoMetrix LLC  

878 Main Street
Buffalo,  NY  14202

United States
https://www.zeptometrix.com
  • Booth: 2601

ZeptoMetrix®, an Antylia Scientific company, is your end-to-end diagnostic assay partner in the design, development, and delivery of innovative solutions for the Infectious Disease and Oncology markets. Our expertise and abilities in microbiology, including molecular controls, immunoassay solutions, and microorganisms have set the industry standard for quality and reliability and make ZeptoMetrix the most trusted brand for independent third-party quality controls.


 Products

  • PROtrol™ SARS-CoV-2
    PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* is the first member of this product line (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix will continue to grow the PROtrol product line, providing high-quality controls to assay manufacturers seeking to expand access to inexpensive and easy-to-use diagnostics....
         

  • ZeptoMetrix® is excited to introduce PROtrol, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

    PROtrol is the only whole organism reference material to provide complete testing data. Each lot of product is supplied with the protein concentration and TCID50 value, which minimizes qualification testing. PROtrol provides better reproducibility, which optimizes the use of financial spending and processing time through the decreased need for repeat testing. 

    PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* is the first member of this product line (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix will continue to grow the PROtrol product line, providing high-quality controls to assay manufacturers.


 Additional Info

We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth?
Yes